Is Selpercatinib/Selpercatinib a targeted drug?

Selpercatinib is a targeted drug, Selpercatinib/SelpercatinibIt is a drug used to treat cancer in people whose tumors have changes (mutation or fusion).

Seputinib/SelpatinibThe most common side effects include laboratory test changes (include increased liver enzymes, increased blood sugar, decreased white blood cell and platelet counts, decreased protein levels, decreased calcium, increased total cholesterol, increased creatinine, and decreased sodium), dry mouth, diarrhea, hypertension, fatigue, edema, rash, and constipation. Selpatinib/Selpatinib is a kinase inhibitor, which means it blocks an enzyme (kinase) that helps prevent cancer cells from growing. Before starting treatment, laboratory testing must be done to identify changes in the RET gene. Sepretinib/Serpatinib is the first therapy approved specifically for patients with cancer and RET genetic alterations.

Before takingseputinib/serpatinib, if you are allergic toseputinib/, any other medicine, or any ingredient in serpatinib capsules, please inform your doctor. Tell your doctor about other prescription and over-the-counter drugs, vitamins, nutritional supplements, and herbal products you are taking or plan to take. If you are taking antacids containing aluminum, magnesium, calcium, or simethicone; or buffered drugs, such as buffered aspirin, take serpatinib at least 2 hours before or at least 2 hours after taking these drugs. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0